EraGen Biosciences' Series B Round

EraGen Biosciences raised a round of funding on November 18, 2009.

EraGen provides clinical laboratories and medical researchers with molecular assays for the early detection and monitoring of diseases. The company's patented MultiCode chemistry is a flexible platfor…

Articles about EraGen Biosciences' Series B Round: